Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04201821 · ClinicalTrials.gov registry record · Phase 1

Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women

A Phase 1 study, sponsored by University of Pennsylvania.

Terminated
Registry status
Phase 1
Development phase
10
Enrollment target

NCT04201821: Clinical Trial Phase 1 study, sponsored by University of Pennsylvania.

NCT04201821 is a Phase 1 study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04201821, a Phase 1 study, was terminated before completion, sponsored by University of Pennsylvania.

TERMINATED
Registry status
Phase 1
Development phase
10 participants
Enrollment target

Study Summary

Open label pilot study assessing FMT to treat fecal incontinence in women 50 years of age and older.

Primary Outcome

The St Marsk's Viazy score is a validated patient-reported instrument used to measure fecal incontinence severity. Score ranges from 0-24 with a decrease in the score representing an improvement. A subject has clinical improvement if they have demonstrated a sustained decrease of 4-5 points between the 4-week and 12-week measurements.

Interventions

  • BIOLOGICAL fecal microbial transplantation (FMT)

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-01-14
Est. Completion 2023-01-18
Phase Phase 1
University of Pennsylvania

1,423 total trials

Why NCT04201821 stopped before completion

NCT04201821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which fecal microbial transplantation (FMT) is the first listed.

NCT04201821 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04201821 about?

NCT04201821 is a clinical study titled "Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women". Open label pilot study assessing FMT to treat fecal incontinence in women 50 years of age and older.

What is the current status of trial NCT04201821?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2021-01-14. Estimated completion is 2023-01-18.

What interventions are being tested in trial NCT04201821?

The interventions under investigation include: fecal microbial transplantation (FMT) (BIOLOGICAL).

Who is sponsoring clinical trial NCT04201821?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04201821's enrollment target sits among peer trials

10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04201821, the US trial registry maintained by the National Library of Medicine. NCT04201821 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.